Symbol
| SLC12A5
| contributors: mct/npt/pgu - updated : 24-10-2015
|
HGNC name
| solute carrier family 12, (potassium-chloride transporter) member 5
|
HGNC id
| 13818
|
corresponding disease(s)
|
EIEE34
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
resulted in fewer mature spontaneously active spinal neurons, more immature silent neurons, and disrupted motor activity | constitutional
|  
|  
| --low
|  
|
in mature neurons in several pathological conditions, including epilepsy and neuropathic pain | constitutional
|  
|  
| --low
|  
|
in the postmortem hippocampus of patients with schizophrenia | constitutional
|  
|  
| --low
|  
|
reduced SLC12A5/SLC12A2 ratio in the cerebrospinal fluid of Rett Syndrome patients, suggesting a disturbed process of GABAergic neuronal maturation | |
Susceptibility
|
to febrile seizures |
Variant & Polymorphism
other
| KCC2-R952H is a bona fide susceptibility variant for febrile seizures (pMID: 24668262) |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | | | |
up-regulation of SLC12A5 function by targeting HTR2A, has therapeutic potential in the treatment of neurological disorders involving altered chloride homeostasis |
| | | |
| two neuron-specific isoforms (KCC2a and KCC2b) in mice. Kcc2a expression in the absence of Kcc2b is presumably sufficient to support vital neuronal functions in the brain stem and spinal cord |